ARCHIVES

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974

Survey Finds. Bush Signs Stopgap Funding Measure;

October 5, 2007

NCI Starts $2 Million Study On Cancer Patient Job Discrimination

January 17, 1975

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

April 26, 1974